Abstract
Since Pauli's 1 observation in 1903 that thiocyanate is effective in reducing high blood pressure, the use of this drug has apparently gained favor. Frequent confirmation of this observation, particularly in recent years, seems to have caused rather general acceptance of thiocyanate therapy as offering, in a selected group of persons with hypertension, a method of meeting a difficult therapeutic problem. Ever since Claude Bernard's 2 first pharmacologic investigation, in 1857, there have been many references to the toxic properties of thiocyanate, but in examining the literature it is noteworthy that, with a few exceptions, mainly its hypotensive property is stressed. The appearance of toxic manifestations thirteen times in a series of seventy-four trials in fifty patients under investigation by us seemed of sufficient importance to report. In two of these thirteen patients there was a fatal outcome. We believe that this is the first report of death in man
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
